MUELLER PETER
Insider CIK 1256126 · BTAI Director · VRTX EVP, Global R&D, CSO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2026-01-09 | 2026-01-12 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2024-06-10 | 2024-06-11 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2023-06-26 | 2023-06-28 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2022-05-19 | 2022-05-23 | 17,000 | — | $0 | 17,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2021-06-11 | 2021-06-15 | 14,500 | — | $0 | 14,500 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2020-05-21 | 2020-05-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2019-08-23 | 2019-08-26 | 1,554 | $9.34 | $14.5K | 168,320 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2019-08-22 | 2019-08-23 | 6,646 | $8.83 | $58.7K | 166,766 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2019-08-21 | 2019-08-23 | 1,800 | $8.42 | $15.2K | 160,120 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2019-05-23 | 2019-05-28 | 14,700 | — | $0 | 14,700 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-07 | 2018-12-07 | 495 | $5.00 | $2.5K | 151,415 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-07 | 2018-12-07 | 6,905 | $5.01 | $34.6K | 158,320 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-06 | 2018-12-07 | 1,295 | $5.00 | $6.5K | 150,820 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-06 | 2018-12-07 | 100 | $5.01 | $501 | 150,920 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-04 | 2018-12-06 | 344 | $5.12 | $1.8K | 147,263 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-04 | 2018-12-06 | 2,062 | $5.15 | $10.6K | 149,525 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-04 | 2018-12-06 | 1,076 | $5.09 | $5.5K | 146,594 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-04 | 2018-12-06 | 200 | $5.13 | $1.0K | 147,463 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | P Buy | 2018-12-04 | 2018-12-06 | 325 | $5.11 | $1.7K | 146,919 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | G Gift | 2018-07-02 | 2020-02-14 | 90,000 | — | $0 | 119,795 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | G Gift | 2018-07-02 | 2020-02-14 | 90,000 | — | $0 | 90,000 | SEC↗ |
| BTAI BioXcel Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-03-13 | 37,209 | — | $0 | 161,397 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-06-16 | 2014-06-18 | 7,500 | — | $0 | 15,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-06-16 | 2014-06-18 | 1,500 | $68.25 | $102.4K | 145,114 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-06-16 | 2014-06-18 | 597 | $69.54 | $41.5K | 144,517 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-06-16 | 2014-06-18 | 1,000 | $70.29 | $70.3K | 143,517 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-06-16 | 2014-06-18 | 4,403 | $67.72 | $298.2K | 146,614 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-06-16 | 2014-06-18 | 7,500 | $32.16 | $241.2K | 151,017 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-05-14 | 2014-05-16 | 7,500 | — | $0 | 23,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-16 | 6,400 | $67.49 | $431.9K | 144,117 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-16 | 500 | $66.13 | $33.1K | 150,517 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-05-14 | 2014-05-16 | 7,500 | $32.16 | $241.2K | 151,017 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-05-14 | 2014-05-16 | 600 | $68.08 | $40.8K | 143,517 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-04-15 | 2014-04-17 | 5,750 | — | $0 | 30,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-04-15 | 2014-04-17 | 1,750 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-04-15 | 2014-04-17 | 700 | $63.27 | $44.3K | 158,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-04-15 | 2014-04-17 | 1,800 | $62.38 | $112.3K | 159,450 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-04-15 | 2014-04-17 | 2,900 | $61.53 | $178.4K | 161,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-04-15 | 2014-04-17 | 2,100 | $60.57 | $127.2K | 164,150 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-04-15 | 2014-04-17 | 5,750 | $32.16 | $184.9K | 166,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-04-15 | 2014-04-17 | 1,750 | $28.84 | $50.5K | 160,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-03-17 | 2014-03-19 | 7,500 | — | $0 | 1,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-03-17 | 2014-03-19 | 6,280 | $78.19 | $491.0K | 159,970 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-03-17 | 2014-03-19 | 7,500 | $28.84 | $216.3K | 166,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-03-17 | 2014-03-19 | 1,220 | $78.78 | $96.1K | 158,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-02-18 | 2014-02-20 | 7,500 | — | $0 | 9,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-02-18 | 2014-02-20 | 633 | $83.05 | $52.6K | 158,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-02-18 | 2014-02-20 | 7,500 | $28.84 | $216.3K | 166,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-02-18 | 2014-02-20 | 6,867 | $82.55 | $566.9K | 159,383 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2014-02-05 | 2014-02-07 | 51,000 | — | $0 | 51,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2014-02-05 | 2014-02-07 | 17,250 | $0.01 | $173 | 158,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2014-01-15 | 2014-01-17 | 7,500 | — | $0 | 16,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2014-01-15 | 2014-01-17 | 7,500 | $78.67 | $590.0K | 141,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2014-01-15 | 2014-01-17 | 7,500 | $28.84 | $216.3K | 149,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-12-16 | 2013-12-17 | 7,500 | — | $0 | 24,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-12-16 | 2013-12-17 | 5,400 | $64.40 | $347.8K | 143,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-12-16 | 2013-12-17 | 2,100 | $65.42 | $137.4K | 141,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-12-16 | 2013-12-17 | 7,500 | $28.84 | $216.3K | 149,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-12-12 | 2013-12-12 | 2,900 | $65.48 | $189.9K | 141,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-11-15 | 2013-11-19 | 3,000 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-11-15 | 2013-11-19 | 4,500 | — | $0 | 31,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-11-15 | 2013-11-19 | 1,100 | $61.58 | $67.7K | 150,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-11-15 | 2013-11-19 | 4,200 | $62.62 | $263.0K | 146,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-11-15 | 2013-11-19 | 2,200 | $63.12 | $138.9K | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-11-15 | 2013-11-19 | 3,000 | $18.93 | $56.8K | 151,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-11-15 | 2013-11-19 | 4,500 | $28.84 | $129.8K | 148,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-10-15 | 2013-10-17 | 7,500 | — | $0 | 3,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-10-15 | 2013-10-17 | 7,500 | $18.93 | $142.0K | 151,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-10-15 | 2013-10-17 | 6,834 | $73.19 | $500.2K | 145,066 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-10-15 | 2013-10-17 | 666 | $73.85 | $49.2K | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-09-16 | 2013-09-17 | 7,500 | — | $0 | 10,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 1,320 | $78.38 | $103.5K | 144,600 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 2,895 | $77.44 | $224.2K | 145,920 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 3,085 | $76.40 | $235.7K | 148,815 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-09-16 | 2013-09-17 | 200 | $79.08 | $15.8K | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-09-16 | 2013-09-17 | 7,500 | $18.93 | $142.0K | 151,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-08-15 | 2013-08-19 | 7,500 | — | $0 | 18,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-08-15 | 2013-08-19 | 3,000 | $77.93 | $233.8K | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-08-15 | 2013-08-19 | 7,500 | $18.93 | $142.0K | 151,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-08-15 | 2013-08-19 | 4,500 | $77.06 | $346.8K | 147,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2013-07-30 | 2013-08-01 | 34,000 | — | $0 | 34,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-07-15 | 2013-07-17 | 7,500 | — | $0 | 25,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-07-15 | 2013-07-17 | 4,965 | $86.17 | $427.8K | 146,935 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-07-15 | 2013-07-17 | 2,535 | $86.66 | $219.7K | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-07-15 | 2013-07-17 | 7,500 | $18.93 | $142.0K | 151,900 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-07-02 | 2013-07-03 | 105,000 | — | $0 | 195,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-07-02 | 2013-07-03 | 9,800 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2013-07-02 | 2013-07-03 | 7,500 | — | $0 | 33,000 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-07-02 | 2013-07-03 | 7,500 | $18.93 | $142.0K | 266,700 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-07-02 | 2013-07-03 | 105,000 | $33.00 | $3.46M | 249,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-07-02 | 2013-07-03 | 68,985 | $79.52 | $5.49M | 183,765 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-07-02 | 2013-07-03 | 13,950 | $78.94 | $1.10M | 252,750 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2013-07-02 | 2013-07-03 | 39,365 | $80.58 | $3.17M | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2013-07-02 | 2013-07-03 | 9,800 | $16.32 | $159.9K | 259,200 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | G Gift | 2013-05-16 | 2013-05-20 | 10,352 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2013-02-05 | 2013-02-07 | 54,375 | — | $0 | 54,375 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2013-02-05 | 2013-02-07 | 12,084 | $0.01 | $121 | 144,400 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-10-15 | 2012-10-16 | 6,500 | — | $0 | 9,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-10-15 | 2012-10-16 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-10-15 | 2012-10-16 | 2,000 | $53.14 | $106.3K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-10-15 | 2012-10-16 | 4,500 | $52.83 | $237.7K | 134,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-09-17 | 2012-09-19 | 6,500 | — | $0 | 16,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-09-17 | 2012-09-19 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-09-17 | 2012-09-19 | 6,500 | $57.52 | $373.9K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-08-15 | 2012-08-17 | 6,500 | — | $0 | 22,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-08-15 | 2012-08-17 | 4,100 | $54.30 | $222.6K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-08-15 | 2012-08-17 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-08-15 | 2012-08-17 | 2,400 | $53.84 | $129.2K | 136,416 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-07-25 | 2012-07-26 | 36,250 | — | $0 | 36,250 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-07-16 | 2012-07-18 | 6,500 | — | $0 | 29,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-07-16 | 2012-07-18 | 4,000 | $52.49 | $210.0K | 134,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-07-16 | 2012-07-18 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-07-16 | 2012-07-18 | 2,500 | $53.24 | $133.1K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-06-15 | 2012-06-19 | 6,500 | — | $0 | 35,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-06-15 | 2012-06-19 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-06-15 | 2012-06-19 | 6,500 | $56.37 | $366.4K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-15 | 2012-05-16 | 6,500 | — | $0 | 42,300 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 700 | $65.50 | $45.9K | 132,316 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 3,700 | $64.30 | $237.9K | 133,016 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-15 | 2012-05-16 | 2,100 | $63.84 | $134.1K | 136,716 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-15 | 2012-05-16 | 6,500 | $16.32 | $106.1K | 138,816 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 51,200 | — | $0 | 48,800 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 3,300 | — | $0 | 0 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise deriv | 2012-05-07 | 2012-05-09 | 25,000 | — | $0 | 40,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 3,300 | $11.27 | $37.2K | 151,536 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 51,200 | $16.32 | $835.6K | 202,736 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-07 | 2012-05-09 | 25,000 | $55.00 | $1.38M | 148,236 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | S Sale | 2012-05-07 | 2012-05-09 | 54,500 | $52.13 | $2.84M | 173,236 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | M Exercise | 2012-05-07 | 2012-05-09 | 25,000 | $18.93 | $473.3K | 227,736 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award deriv | 2012-02-02 | 2012-02-06 | 72,500 | — | $0 | 72,500 | SEC↗ |
| VRTX VERTEX PHARMACEUTICALS INC | A Award | 2012-02-02 | 2012-02-06 | 14,501 | $0.01 | $145 | 148,236 | SEC↗ |